ABT · 10-Q · 2026Q2 · Full report
Diagnostic Market Demand
ABBOTT LABORATORIES · 2026-07-28 · Importance 61 · Surprise 66 · From source text
Diagnostic Products sales increased 22.4% excluding foreign exchange in the first six months of 2026, with growth from Exact Sciences and Core Laboratory partly offset by Rapid and Molecular Diagnostics weakness. Exact Sciences contributed approximately $1.0 billion of sales from March 23, 2026, reported within Cancer Diagnostics. Core Laboratory sales grew 3.2% excluding foreign exchange, supported by diagnostic tests on the Alinity platform in the U.S. and Latin America. Rapid and Molecular Diagnostics sales declined 8.8% because demand for respiratory virus tests fell amid a weaker respiratory virus season.
Key facts
- Core Laboratory sales for the six months ended June 30, 2026 were $2,690 million versus $2,535 million in 2025, an increase of 6.1% (2.9% FX impact, 3.2% excl. FX).
- In the first six months of 2026, Diagnostic Products sales increased 22.4% excluding the impact of foreign exchange.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +0.7% | Core Laboratory sales for the six months ended June 30, 2026 were $2,690 million versus $2,535 million in 2025, an increase of 6.1% (2.9%… |